Bio

Real World Evidence (RWE) PhD scientist and thought leader trained in epidemiology and health economics at Cambridge, Harvard and Oxford. I develop and drive RWE strategies using innovative approaches to deliver high-impact scientific robust evidence for US and international markets, and use data analytics to predict disease outcomes, identify high-risk populations, healthcare resource utilisation and potential cost-savings, and estimate the market value of healthcare innovations. I am passionate about using epidemiology and bridging data-driven science with clinical practice and healthcare innovation with the aim to improve patient outcomes whilst ensuring return on investment. Expertise: methodology, electronic health records, claims, strategy, partnerships, value and access, HEOR, predictive modelling, pharmacoepidemiology, health economics, (early) health technology assessment, biostatistics, multiple imputation, biobanks, registries, research collaborations.